Achemica | Switzerland | Inquire | ||
---|---|---|---|---|
![]() |
+41 (24) 466-2929 | |||
![]() |
contact@achemica.com | |||
Chemical manufacturer since 2010 | ||||
Anward | Hong Kong | Inquire | ||
---|---|---|---|---|
![]() |
+852 8191 6999 | |||
![]() |
sales@anward.com | |||
Chemical manufacturer since 2012 | ||||
Bide Pharmatech Ltd. | China | Inquire | ||
---|---|---|---|---|
![]() |
+86 4006-147-117 | |||
![]() |
sales@bidepharmatech.com | |||
![]() |
QQ Chat | |||
Chemical manufacturer since 2007 | ||||
ChemBridge Corporation | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (858) 451-7400 | |||
![]() |
sales@chembridge.com | |||
Chemical manufacturer | ||||
ChemDiv, Inc. | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (858) 794-4860 | |||
![]() |
chemdiv@chemdiv.com | |||
Chemical manufacturer | ||||
International Laboratory Limited | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (650) 278-9963 | |||
![]() |
admin@intlab.org | |||
Chemical manufacturer since 2002 | ||||
OX CHEM | USA | Inquire | ||
---|---|---|---|---|
![]() |
+1 (626) 461-2812 | |||
![]() |
sales@ox-chem.com | |||
CRO since 2013 | ||||
Zylexa Pharma Ltd. | UK | Inquire | ||
---|---|---|---|---|
![]() |
+44 (845) 299-6009/ | |||
![]() |
sales@zylexa-pharma.com,enquiries@zylexa-pharma.com | |||
Chemical manufacturer | ||||
Name | 5-Benzyl-3-(4-bromophenyl)-1,2,4-oxadiazole |
---|---|
Synonyms | 5-Benzyl-3-(4-bromophenyl)-1,2,4-oxadiazole; MFCD03705320 |
Molecular Structure | ![]() |
Molecular Formula | C15H11BrN2O |
Molecular Weight | 315.16 |
CAS Registry Number | 864836-24-8 |
SMILES | Brc3ccc(c1nc(on1)Cc2ccccc2)cc3 |
InChI | 1S/C15H11BrN2O/c16-13-8-6-12(7-9-13)15-17-14(19-18-15)10-11-4-2-1-3-5-11/h1-9H,10H2 |
InChIKey | LGZMKORRYZIXDY-UHFFFAOYSA-N |
Density | 1.436g/cm3 (Cal.) |
---|---|
Boiling point | 442.631°C at 760 mmHg (Cal.) |
Flash point | 221.496°C (Cal.) |
Refractive index | 1.612 (Cal.) |
SDS | Available |
---|---|
Market Analysis Reports |
List of Reports Available for 5-Benzyl-3-(4-bromophenyl)-1,2,4-oxadiazole |